Medicare Enrolled

Dr. John Weinhold, MD

Medical Oncology · Olean, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
535 MAIN ST, Olean, NY 14760
7163720141
In practice since 2005 (20 years)
NPI: 1265417737 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Weinhold from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weinhold? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Weinhold

Dr. John Weinhold is a medical oncology specialist in Olean, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Weinhold performed 668 Medicare services across 329 unique beneficiaries.

Between the years covered by Open Payments, Dr. Weinhold received a total of $11,719 from 56 pharmaceutical and/or device companies across 640 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Weinhold is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 25% volume in NY $11,719 industry payments

Medicare Practice Summary

Medicare Utilization ↗
668
Medicare services
Top 25% in NY for medical oncology
329
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~33 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
340 $69 $228
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
220 $101 $318
New patient office visit, complex (60-74 min) 36 $123 $450
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
26 $91 $220
Same-day hospital admission and discharge, high complexity
Initial hospital care for a patient admitted and discharged on the same day, involving a high level of medical decision making. This service requires at least 85 minutes of time spent on the day of the visit.
25 $160 $490
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
21 $61 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,719
Total received (2018-2024)
Avg $1,674/year across 7 years
Top 42% in NY for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
640
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,109 (94.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$610 (5.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,223
2023
$720
2022
$212
2021
$31
2020
$2,414
2019
$3,440
2018
$3,679

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$261
Janssen Biotech, Inc.
$152
AstraZeneca Pharmaceuticals LP
$125
Astellas Pharma US Inc
$82
ABBVIE INC.
$77
Daiichi Sankyo Inc.
$61
Regeneron Healthcare Solutions, Inc.
$56
Incyte Corporation
$53
Genentech USA, Inc.
$51
PFIZER INC.
$39
Coherus Biosciences Inc.
$34
Genmab U.S., Inc.
$30
Tactile Systems Technology Inc
$26
Merck Sharp & Dohme LLC
$26
Lilly USA, LLC
$23
Gilead Sciences, Inc.
$23
Ipsen Biopharmaceuticals, Inc
$21
Exelixis Inc.
$21
Novartis Pharmaceuticals Corporation
$19
Karyopharm Therapeutics Inc.
$16
E.R. Squibb & Sons, L.L.C.
$16
PUMA BIOTECHNOLOGY, INC.
$14
Top 3 companies account for 44.0% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$926
E.R. Squibb & Sons, L.L.C.
$870
Amgen Inc.
$867
Novartis Pharmaceuticals Corporation
$845
Janssen Biotech, Inc.
$746
AstraZeneca Pharmaceuticals LP
$718
PFIZER INC.
$651
Pharmacyclics LLC, An AbbVie Company
$575
GENZYME CORPORATION
$573
Celgene Corporation
$518
Genentech USA, Inc.
$492
Incyte Corporation
$431
Astellas Pharma US Inc
$366
Daiichi Sankyo Inc.
$329
Clovis Oncology, Inc.
$310
Lilly USA, LLC
$303
AbbVie, Inc.
$161
Boehringer Ingelheim Pharmaceuticals, Inc.
$148
Bayer HealthCare Pharmaceuticals Inc.
$118
Regeneron Healthcare Solutions, Inc.
$114
Alexion Pharmaceuticals, Inc.
$112
BeiGene USA, Inc.
$97
CSL Behring
$96
Rigel Pharmaceuticals, Inc.
$89
ARRAY BIOPHARMA INC
$82
Apellis Pharmaceuticals, Inc.
$79
ABBVIE INC.
$77
Puma Biotechnology, Inc.
$65
Eisai Inc.
$64
Seagen Inc.
$64
EISAI INC.
$64
Gilead Sciences, Inc.
$55
Verastem, Inc.
$51
Takeda Pharmaceuticals U.S.A., Inc.
$50
Sun Pharmaceutical Industries Inc.
$48
Tactile Systems Technology Inc
$47
Taiho Oncology, Inc.
$46
Merck Sharp & Dohme LLC
$46
Ipsen Biopharmaceuticals, Inc
$42
TOLMAR Pharmaceuticals, Inc.
$38
GlaxoSmithKline, LLC.
$37
Coherus Biosciences Inc.
$34
Genmab U.S., Inc.
$30
Helsinn Therapeutics (U.S.), Inc.
$27
EMD Serono, Inc.
$23
Pharmacyclics LLC, an AbbVie Company
$22
Teva Pharmaceuticals USA, Inc.
$22
Exelixis Inc.
$21
SANOFI-AVENTIS U.S. LLC
$20
TAIHO ONCOLOGY, INC.
$18
Shire North American Group Inc
$17
Karyopharm Therapeutics Inc.
$16
Lexicon Pharmaceuticals, Inc.
$15
Jazz Pharmaceuticals Inc.
$15
APTEVO THERAPEUTICS INC
$14
PUMA BIOTECHNOLOGY, INC.
$14
Top 3 companies account for 22.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · Abraxane · Alecensa · Aranesp · Avastin · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · CABOMETYX · CALQUENCE · CEREZYME · CHANTIX · CYRAMZA · Columvi · Copiktra · DARZALEX · ELIGARD · ELIQUIS · ELITEK · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · Flexitouch Plus · GAUCHER-DISEASE · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · IXINITY · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · ODOMZO · OPDIVO · OPDUALAG · Onivyde · PEMAZYRE · PIQRAY · PROMACTA · Padcev · Perjeta · Pomalyst · Prolia · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Revlimid · Rubraca · SANDOSTATIN · SARCLISA · SHINGRIX · SOLIRIS · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Tavalisse · Tazverik · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIAGRA · VONVENDI · Venclexta · Vyloy · XALKORI · XARELTO · XPOVIO · XTANDI · XYNTHA · Xermelo · Xofigo · Xtandi · YONSA · ZEPOSIA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a medical oncology specialist in Olean?
Compare medical oncologists in the Olean area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
2
Per 100K population
2.6
County median income
$58,248
Nearest hospital
OLEAN GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Weinhold is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Weinhold experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Weinhold performed 340 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weinhold receive payments from pharmaceutical companies?
Yes. Dr. Weinhold received a total of $11,719 from 56 companies across 640 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weinhold's costs compare to other medical oncologists in Olean?
Dr. Weinhold's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weinhold) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →